0001209191-18-010105.txt : 20180214 0001209191-18-010105.hdr.sgml : 20180214 20180214180640 ACCESSION NUMBER: 0001209191-18-010105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180212 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18614741 MAIL ADDRESS: STREET 1: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-12 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 CEO & President Common Stock 2018-02-12 4 S 0 6100 149.22 D 208463 D Common Stock 2018-02-12 4 S 0 4305 150.44 D 204158 D Common Stock 2018-02-12 4 S 0 10100 151.23 D 194058 D Common Stock 2018-02-12 4 S 0 1200 152.40 D 192858 D Common Stock 2018-02-12 4 S 0 2000 153.29 D 190858 D Common Stock 2018-02-12 4 S 0 200 153.89 D 190658 D Common Stock 440 I 401(k) Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.74). Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.79 to $150.76). Open market sales reported on this line occurred at a weighted average price of $151.23 (range $150.83 to $151.82). Open market sales reported on this line occurred at a weighted average price of $152.40 (range $151.85 to $152.81). Open market sales reported on this line occurred at a weighted average price of $153.29 (range $152.88 to $153.84). Open market sales reported on this line occurred at a weighted average price of $153.89 (range $153.88 to $153.89). /s/ Omar White, Attorney-in-Fact 2018-02-14